SCHEMBL4999366

SCHEMBL4999366

COc1c(C(=O)NN)cc(C(C)C)c(OC)c1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
ALDH1A1 P00352 4/20 0.45
GAA P10253 1/20 0.45
CTSD P07339 1/20 0.42
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
RARG P13631 1/20 0.37
RXRA P19793 1/20 0.37
PPARG P37231 1/20 0.37
MAPK1 P28482 1/20 0.37
POLB P06746 2/20 0.37
KCNK3 O14649 1/20 0.37
KCNK9 Q9NPC2 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
MAPT P10636 3/20 0.37
BCL2 P10415 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
LMNA P02545 1/20 0.35
GFER P55789 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5002642 0.80 HSD17B10 (0.47) KDM4EALDH1A1RARGRXRAPPARG
SCHEMBL28118962 0.77 CTSD (0.50) KDM4EALDH1A1GAACTSDMAPK1
SCHEMBL4999418 0.77 ALDH1A1 (0.47) KDM4EALDH1A1GAACTSDCA1
SCHEMBL24414092 0.73 RARG (0.41) ALDH1A1RARGRXRAPPARGMAPK1
SCHEMBL501296 0.71 GAA (0.50) KDM4EALDH1A1GAAPOLBMAPT
SCHEMBL14924904 0.71 KDM4E (0.43) KDM4EALDH1A1GAAMAPTBCL2
SCHEMBL4999364 0.70 CTSD (0.39) KDM4EALDH1A1CTSDCA1CA2
SCHEMBL17356881 0.69 MAPT (0.47) KDM4EALDH1A1GAAPOLBMAPT
SCHEMBL2722031 0.69 HSD17B10 (0.65) KDM4EALDH1A1GAACTSDSMN1; SMN2
SCHEMBL16638210 0.69 PKM (0.51) KDM4EALDH1A1GAAMAPK1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130116431-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116253-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116251-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
US-20130116252-A1 Novel HSP90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-05-09 US disclosed
EP-1857446-B1 Derivatives of 3-(2,4-dihydroxyphenyl)-1,2,4-triazole useful in the treatment of cancer NIPPON KAYAKU KK (JP) 2013-05-01 EP disclosed
US-8399464-B2 using a triazole compound; anticancer agent NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-03-19 US disclosed
US-20080269218-A1 Novel Hsp90 Inhibitor NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-10-30 US disclosed
EP-1857446-A1 NOVEL HSP90 INHIBITOR Nippon Kayaku Kabushiki Kaisha (JP) 2007-11-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116252-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 KDM4E 3055/4885ALDH1A1 873/4885GAA 836/4885
US-20130116253-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 KDM4E 3055/4885ALDH1A1 873/4885GAA 836/4885
US-20080269218-A1 Novel Hsp90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 KDM4E 2991/4885ALDH1A1 1437/4885GAA 913/4885
US-20130116251-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 KDM4E 3055/4885ALDH1A1 873/4885GAA 836/4885
US-20130116431-A1 Novel HSP90 Inhibitor HSP90AB1, HSP90AB2P, HSP90B1 KDM4E 3055/4885ALDH1A1 873/4885GAA 836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.